• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    APx Acquisition Corp. I Receives NASDAQ Notification of Non-Compliance With Listing Rules

    8/25/22 4:25:00 PM ET
    $APXI
    Blank Checks
    Finance
    Get the next $APXI alert in real time by email

    APx Acquisition Corp. I (NASDAQ:APXI) ("APx" or the "Company"), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, announced that on August 23, 2022, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market ("NASDAQ") advising the Company that the Company did not comply with NASDAQ's Listing Rule 5250(c)(1) for continued listing because NASDAQ had not received the Company's Quarterly Report on Form 10-Q for the period ended June 30, 2022 (the "Form 10-Q").

    NASDAQ informed the Company that it has until October 24, 2022 to submit a plan to regain compliance with respect to this delinquent report. If NASDAQ approves the Company's plan, it has the discretion to grant the Company an extension of up to 180 calendar days from the due date of the Form 10-Q, or until February 20, 2023, to regain compliance.

    The Company is working diligently to complete the Form 10-Q and certain other amended reports, as previously disclosed in its Current Report on Form 8-K filed with the Securities and Exchange Commission (the "SEC") on August 19, 2022. If the Company is unable to file the Form 10-Q by October 24, 2022, it intends to file a plan to regain compliance with NASDAQ. This notification has no immediate effect on the listing of the Company's securities on NASDAQ. There can be no assurance, however, that the Company will be able to file Form 10-Q by October 24, 2022, regain compliance with the listing requirements discussed above or otherwise satisfy the other NASDAQ listing criteria.

    About APx Acquisition Corp. I

    APx Acquisition Corp. I is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

    Forward Looking Statements

    This press release contains statements that constitute "forward-looking statements," including with respect to, among others, statements about the Company's plans to file its Form 10-Q and amend prior SEC filings, including the restatement of certain consolidated financial statements included therein. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "is working," "may," "should," "could," "would," "expect," "plan," "anticipate," "believe," "estimate," "continue," or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our SEC filings. Copies of these documents are available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20220825005705/en/

    Get the next $APXI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APXI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $APXI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Bransfield Kyle P disposed of 100,000 units of Class A ordinary shares and acquired 100,000 units of Class A ordinary shares (SEC Form 4)

    4 - APx Acquisition Corp. I (0001868573) (Issuer)

    7/31/24 9:45:03 PM ET
    $APXI
    Blank Checks
    Finance

    Bransfield Kyle P disposed of 800,000 units of Class A ordinary shares and acquired 800,000 units of Class A ordinary shares (SEC Form 4)

    4 - APx Acquisition Corp. I (0001868573) (Issuer)

    3/25/24 5:00:06 PM ET
    $APXI
    Blank Checks
    Finance

    Bransfield Kyle P converted options into 3,342,188 units of Class A ordinary shares (SEC Form 4)

    4 - APx Acquisition Corp. I (0001868573) (Issuer)

    2/8/24 9:05:08 PM ET
    $APXI
    Blank Checks
    Finance

    $APXI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    APX Acquisition Corp. I Announces Nasdaq Delisting Notification for Warrants and Units

    NASHVILLE, Tenn., Nov. 1, 2024 /PRNewswire/ -- As previously announced, on September 4, 2024, APX Acquisition Corp. I (NASDAQ: APXI) (the "Company"), received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") indicating that since the Company's aggregate market value of its outstanding warrants was less than $1 million, the Company was no longer in compliance with the Nasdaq Global Market continued listing criteria set forth in Listing Rule 5452(b)(C) (the "Rule"), which requires the Company to maintain an aggregate market value of its outstanding warrants of at least $1 million (the "Notice"). The Company subsequently submitted a plan to regai

    11/1/24 5:48:00 PM ET
    $APXI
    Blank Checks
    Finance

    APX Acquisition Corp. I Reports 10-K Delinquency Notice

    NASHVILLE, Tenn., June 5, 2024 /PRNewswire/ -- APX Acquisition Corp. I (NASDAQ: APXI) ("Company"), a publicly traded special purpose acquisition company, today announced that it received a deficiency letter (the "Letter") on May 30, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq"). The Letter notified the Company that since the Company had not yet filed its Annual Report on Form 10-K for the year ended December 31, 2023 (the "Form 10-K") and its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the "Form 10-Q"), the Company does not comply with Nasdaq's Listing Rule 5250(c)(1) relating to the Company's obligation to file periodic financi

    6/5/24 1:33:00 PM ET
    $APXI
    Blank Checks
    Finance

    APx Acquisition Corp. I, OmnigenicsAI Corp and MultiplAI Health Ltd enter into Business Combination Agreement to create a global AI-driven genomics platform

    NASHVILLE, Tenn., March 26, 2024 /PRNewswire/ -- APx Acquisition Corp. I (NASDAQ:APXI) ("APx"), a publicly traded special purpose acquisition company, OmnigenicsAI Corp ("OmnigenicsAI"), a precision medicine company incubated by Bioceres Group PLC, and MultiplAI Health Ltd ("MultiplAI"), a UK-based AI-enabled preventive medicine company, have entered into a definitive Business Combination Agreement ("BCA") that, upon closing, would result in OmnigenicsAI becoming a publicly listed company. The transaction is expected to close mid-year, subject to the approval of APx's shareholders and other customary closing conditions and, upon closing, OmnigenicsAI's shares are expected to be listed on Nas

    3/26/24 8:25:00 AM ET
    $APXI
    Blank Checks
    Finance

    $APXI
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by APx Acquisition Corp. I

    SCHEDULE 13G - APx Acquisition Corp. I (0001868573) (Subject)

    1/7/25 4:31:51 PM ET
    $APXI
    Blank Checks
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by APx Acquisition Corp. I

    SCHEDULE 13G/A - APx Acquisition Corp. I (0001868573) (Subject)

    1/7/25 11:47:26 AM ET
    $APXI
    Blank Checks
    Finance

    SEC Form 8-K filed by APx Acquisition Corp. I

    8-K - APx Acquisition Corp. I (0001868573) (Filer)

    12/16/24 4:05:25 PM ET
    $APXI
    Blank Checks
    Finance

    $APXI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by APx Acquisition Corp. I

    SC 13G - APx Acquisition Corp. I (0001868573) (Subject)

    11/14/24 8:51:50 PM ET
    $APXI
    Blank Checks
    Finance

    SEC Form SC 13G filed by APx Acquisition Corp. I

    SC 13G - APx Acquisition Corp. I (0001868573) (Subject)

    11/14/24 4:18:23 PM ET
    $APXI
    Blank Checks
    Finance

    Amendment: SEC Form SC 13G/A filed by APx Acquisition Corp. I

    SC 13G/A - APx Acquisition Corp. I (0001868573) (Subject)

    10/16/24 9:19:30 AM ET
    $APXI
    Blank Checks
    Finance